Aigh Capital Management LLC X4 Pharmaceuticals, Inc Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.48 - $2.58 $690,242 - $1.2 Million	-466,380 Reduced 31.85%	997,719 $1.75 Million
Q4 2021 Feb 10, 2022	SELL	$1.9 - $5.6 $380,837 - $1.12 Million	-200,441 Reduced 12.04%	1,464,099 $3.35 Million
Q3 2021 Nov 12, 2021	BUY	$4.53 - $6.45 $1.02 Million - $1.46 Million	225,641 Added 15.68%	1,664,540 $8.81 Million
Q2 2021 Aug 12, 2021	BUY	$6.49 - $9.56 $9.34 Million - $13.8 Million	1,438,899 New	1,438,899 $9.35 Million

106

103M

206K

291K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $39.8M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.